Clinical Trials Logo

Filter by:
NCT ID: NCT06161415 Recruiting - Inflammation Clinical Trials

Safety, Tolerability, and Distribution of Laquinimod Eye Drops : The LION Study

LION
Start date: April 2024
Phase: Phase 1
Study type: Interventional

The LION Study is a prospective, single-center phase 1 clinical trial to evaluate the safety, tolerability, and distribution of Laquinimod administered as topical eye drops for two weeks in human participants.

NCT ID: NCT06161337 Recruiting - Healthy Volunteers Clinical Trials

ChronoMet: Metabolic and Inflammatory Effects of Eating Timing and Quantity

Start date: February 12, 2024
Phase: N/A
Study type: Interventional

This is an observational study to address the important knowledge gap of the metabolic and inflammatory impact of acute overeating and whether timing of acute overeating may modify these effects. The hypothesis is that acute overconsumption of calories will promote inflammation and metabolic dysfunction, with the most detrimental effects observed with evening caloric overconsumption. The expectation is that this study to provide critical insights into the biological consequences of overeating, which will direct novel approaches combating overeating and its detrimental health effects.

NCT ID: NCT06161246 Completed - Clinical trials for Injection Site Discomfort

A Controlled Study on Pain Management With Injection of Botulinum Toxin for Glabellar Line Correction

Start date: October 23, 2023
Phase: Phase 4
Study type: Interventional

This is an open-label, single-center, randomized, split-face, controlled study to assess the effect of comfort intervention on pain during treatment injection compared against non-comfort intervention.

NCT ID: NCT06161220 Completed - Clinical trials for Cardiac Repolarization in Healthy Subjects

A TQT Study to Evaluate the Electrocardiographic Effects of Carbidopa in Healthy Subjects

Start date: October 30, 2023
Phase: Phase 1
Study type: Interventional

The purpose of this trial is to assess the effects of a single supratherapeutic dose of carbidopa on cardiac repolarization relative to placebo in healthy adult subjects.

NCT ID: NCT06161116 Recruiting - Clinical trials for Systemic Lupus Erythematosus

Efficacy And Safety Of MK-6194 In Adult Participants With Systemic Lupus Erythematosus (MK-6194-006)

Start date: December 27, 2023
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of MK-6194 in adult participants with Systemic Lupus Erythematosus. The primary hypothesis is that at least 1 of the MK-6194 arms is superior to placebo in the primary endpoint of percentage of participants with systemic lupus erythematosus responder index (SRI-4) response at Week 28.

NCT ID: NCT06161077 Not yet recruiting - Clinical trials for Idiopathic Subglottic Tracheal Stenosis

Voice Quality Analysis of Patients With Laryngotracheal Stenosis

Start date: July 1, 2024
Phase:
Study type: Observational

The investigators previously demonstrated that voice changes are common in patients with Laryngotracheal Stenosis (LTS), and patients typically report an improvement in voice outcomes following endoscopic dilation. Recently, NIH based programs such as a Bridge to Artificial Intelligence (Bridge2AI) have highlighted the use of artificial intelligence to identify acoustic biomarkers of disease. Therefore, the investigators hypothesize that progression of LTS scar can be quantified using acoustic measurements and machine learning. The goal of this clinical trial is to remotely monitor patient voice quality in an effort to determine if regularly performed voice recordings can be used as a diagnostic tool in order to predict the need for dilation procedures. The investigators feel that successful use of remote voice recording technology with algorithmic analysis will improve patient quality of life.

NCT ID: NCT06161051 Completed - Clinical trials for Advanced Non-small Cell Lung Cancer and MET Exon 14 Skipping Mutation

Treatment Patterns and Real-World Clinical Outcomes in Patients With Advanced NSCLC and MET Exon 14 Skipping Mutation in the United States

Start date: October 3, 2022
Phase:
Study type: Observational

This was a retrospective, noninterventional cohort study of patients with a confirmed diagnosis of advanced non-small cell lung cancer (aNSCLC) with MET exon 14 skipping mutation who received treatment with capmatinib, immunotherapy (IO), or chemotherapy (CT) in real-world practice settings. Data abstraction was performed by the participating physician.

NCT ID: NCT06161012 Completed - Ocular Physiology Clinical Trials

Evaluation of Delefilcon A and Senofilcon A Daily Disposable Toric Soft Contact Lenses Over Two Weeks of Wear

Start date: November 16, 2023
Phase: N/A
Study type: Interventional

This will be a multi-site, bilateral, dispensing, randomized, controlled, double-masked, 2×2 crossover study to evaluate ocular physiological response.

NCT ID: NCT06160986 Recruiting - Quality of Life Clinical Trials

Horizons Chronic Graft-Versus-Host-Disease Study

Start date: December 27, 2023
Phase: N/A
Study type: Interventional

This research is being done to evaluate the feasibility of the Horizons Program, a group-based behavioral intervention, to enhance quality of life in patients with chronic graft-versus-host disease.

NCT ID: NCT06160973 Recruiting - Diet, Healthy Clinical Trials

Food as Medicine for Families

FAME-F
Start date: February 13, 2024
Phase: N/A
Study type: Interventional

The goal of this study is to determine the appropriate target of medically tailored meals (a particular individual vs. the entire household) and means of delivery (a dedicated delivery driver vs. a commercial shipper), to inform subsequent medically tailored meal trials.